X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.ema.europa.eu/en/documents/overview/lutetium-177lu-chloride-billev-previously-illuzyce-epar-medicine-overview_en.pdf
https://www.pharmacompass.com/pdf/news/billevs-illuzyce-lutetium-177lu-chloride-receives-approval-in-europe-26853.pdf
https://www.world-today-news.com/mtti-and-monrol-sign-supply-agreement-for-the-clinical-material-lu-177-nca/
https://endpts.com/fda-reverses-course-decides-not-to-add-suffixes-to-older-biologics-nonproprietary-names/
https://www.fiercebiotech.com/biotech/y-mabs-preps-92m-ipo-to-push-lead-assets-through-regulatory-filing
http://investor.endocyte.com/news-releases/news-release-details/endocyte-and-itm-announce-long-term-supply-agreement-no-carrier
http://investor.endocyte.com/news-releases/news-release-details/endocyte-announces-pricing-public-offering-common-stock
http://www.globenewswire.com/news-release/2018/02/26/1387297/0/en/Endocyte-and-ITM-Announce-Supply-Agreement-for-No-Carrier-Added-Lutetium-for-the-Phase-3-VISION-Trial.html
http://www.pharmatimes.com/news/us_clears_new_option_for_gastroenteropancreatic_tumours_1219092
https://endpts.com/novartis-scores-a-quick-fda-ok-for-its-new-cancer-drug-lutathera-picked-up-in-4b-buyout/
https://www.pharmacompass.com/pdf/news/advanced-accelerator-applications-lutathera-lutetium-177lu-oxodotreotide-receives-approval-in-europe-1516425566.pdf
http://www.nasdaq.com/article/advanced-accelerator-gets-action-date-for-lutathera-from-fda-cm838886
https://globenewswire.com/news-release/2017/01/18/909143/0/en/Telix-Pharmaceuticals-and-Atlab-Pharma-Conclude-Therapeutic-Product-Development-Agreement-for-Prostate-Cancer.html
Market Place
Share 
